Close X
Tuesday, November 26, 2024
ADVT 
Health

Indian-American Researchers Unleash Turmeric’s Power To Fight Cancer

IANS, 13 Aug, 2018 12:35 PM
    A team of Indian-American researchers at the University of Illinois at Urbana-Champaign (UIUC) and at the University of Utah at Salt Lake City, has used an ingenious process to enable curcumin to kill cancer cells.
     
     
    Curcumin is the active ingredient of turmeric (haldi), the ubiquitous kitchen spice that gives curry its yellow color. Turmeric has been used in India for thousands of years as a spice and medicinal herb because of its powerful anti-inflammatory and strong antioxidant property.
     
     
    Curcumin is also known to exhibit anti-cancer properties, but its poor solubility in water had impeded curcumin's clinical application in cancer. A drug needs to be soluble in water as otherwise it will not flow through the bloodstream.
     
     
    Despite decades of research, the development of efficient strategies that can effectively deliver poorly water-soluble curcumin to cancer cells had remained a challenge.
     
     
    A team headed by Dipanjan Pan, associate professor of bioengineering at UIUC, has now found a way out.
     
     
    "Curcumin's medicinal benefit can be fully appreciated if its solubility issue is resolved," Pan told this correspondent in an e-mail.
     
     
    Pan's laboratory collaborated with Peter Stang at the University of Utah on ways to be able to render curcumin soluble, deliver it to infected tumors and kill the cancer cells.
     
     
    Because platinum is a commonly used cancer therapeutic agent in the clinic, the researchers decided to experiment with a drug consisting of a combination of platinum and curcumin.
     
     
    "It is a combination of clever chemistry and nano-precipitation utilising host guest chemistry," Pan explained. "The sophisticated chemistry leads to self-assembled hierarchical structure that drives the solubility of curcumin and simultaneously delivers an additional anticancer agent, i.e. platinum. The combined therapeutic effect -- of curcumin and platinum -- is lethal for the cancer cells."
     
     
    The team has reported its work in the "Proceedings of the National Academy of Sciences" in the US.
     
     
    According to their report, the metallocyclic complex created using platinum "not only enabled curcumin's solubility, but proved to be 100 times more effective in treating various cancer types such as melanoma and breast cancer cells than using curcumin and platinum agents separately".
     
     
    "Our results demonstrate that curcumin works completely in sync with platinum and exerts synergistic effect to show remarkable anticancer properties," says the report. "The platinum-curcumin combination kills the cells by fragmenting its DNA."
     
     
    "Extensive animal studies are in progress in my laboratory, including in rodents and pigs," Pan said. His team also hopes to prove that this method will be effective in killing cancer stem cells -- the birth place of cancer cells -- thereby preventing the recurrence of cancer.
     
     
    Pan's team included post-doctoral researcher Santosh Misra at UIUC, and Sougata Datta, Manik Lal Saha, Nabajit Lahiri, Janis Louie, and Peter J. Stang from the University of Utah.

    MORE Health ARTICLES

    Myths About Noon Nap Busted

    Myths About Noon Nap Busted
    It is often believed that an afternoon nap can do a body good. But there are people who are not convinced with the power of the afternoon snooze.

    Myths About Noon Nap Busted

    Regulation of brain molecule could help marijuana addicts

    Regulation of brain molecule could help marijuana addicts
    A natural molecule that activates cannabinoid receptors in the brain could relieve mood and anxiety disorders and enable some people to quit....

    Regulation of brain molecule could help marijuana addicts

    Even mild heart disease increases mortality risk for diabetic patients

    Even mild heart disease increases mortality risk for diabetic patients
    A large-scale study involving 40,000 patients from 17 centres around the world has found that diabetic patients with even mild coronary artery disease face...

    Even mild heart disease increases mortality risk for diabetic patients

    'Ebola vaccine showing promising results'

    'Ebola vaccine showing promising results'
    Two Ebola vaccines undergoing clinical trials have shown promising results and would be deployed in January 2015 to West African countries affected by the...

    'Ebola vaccine showing promising results'

    US Institute To Study Sexual Habits Of Obese Girls

    US Institute To Study Sexual Habits Of Obese Girls
    The US National Institute for Health (NIH) has collaborated with researchers from the University of Pittsburgh' Magee-Women's Research Institute to study the sexual habits of obese girls.

    US Institute To Study Sexual Habits Of Obese Girls

    Toy-related Injuries On The Rise In US

    Toy-related Injuries On The Rise In US
    The study highlights that while playing with toys helps children to develop, learn, and explore, parents should also note that many toys pose an injury risk to children.

    Toy-related Injuries On The Rise In US